Location: New York, NY
CIK: 0001534261 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $1.321B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AGMB | AGOMAB THERAPEUTICS NV | 1,550,000 | $16.26M | 1.2% | $10.49 | — | SPONSORED ADS | 00860C102 |
| QGEN | QIAGEN NV | 360,000 | $14.41M | 1.1% | $50.32 | 0.0% | ORD SHARES | N72482156 |
| GRAL | GRAIL INC | 230,000 | $11.89M | 0.9% | $94.37 | 0.0% | COM | 384747101 |
| PSNL | PERSONALIS INC | 1,600,000 | $10.19M | 0.8% | $8.94 | 0.0% | COM | 71535D106 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 450,000 | $8.388M | 0.6% | $16.05 | 0.0% | CLASS A ORD | 61559X104 |
| NTLA | INTELLIA THERAPEUTICS INC | 355,000 | $4.551M | 0.3% | $12.40 | 0.0% | COM | 45826J105 |
| IRON | DISC MEDICINE INC | 65,000 | $4.156M | 0.3% | $74.04 | 0.0% | COM | 254604101 |
| MRNA | MODERNA INC | 75,000 | $3.81M | 0.3% | $42.94 | 0.0% | COM | 60770K107 |
| ANL | ADLAI NORTYE LTD | 538,461 | $3.726M | 0.3% | $6.92 | — | SPONSORED ADS | 00704R109 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RLAY | RELAY THERAPEUTICS INC | 14,418,574 (+10.9%) | $143M (+30.4%) | 10.9% | $14.46 | -42.6% | COM | 75943R102 |
| TXG | 10X GENOMICS INC | 2,275,000 (+62.5%) | $48.3M (+111.5%) | 3.7% | $16.93 | +17.2% | CL A COM | 88025U109 |
| TSHA | TAYSHA GENE THERAPIES INC | 3,250,000 (+116.7%) | $14.53M (+76.1%) | 1.1% | $4.80 | -0.9% | COM SHS | 877619106 |
| SRRK | SCHOLAR ROCK HLDG CORP | 350,000 (+34.6%) | $17.21M (+50.2%) | 1.3% | $39.55 | +15.0% | COM | 80706P103 |
| HIMS | HIMS & HERS HEALTH INC | 700,000 (+81.8%) | $14.53M (+16.2%) | 1.1% | $33.43 | -24.2% | COM CL A | 433000106 |
| NGNE | NEUROGENE INC | 1,420,361 (+9.6%) | $28.63M (+7.3%) | 2.2% | $27.08 | -33.0% | COM | 64135M105 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 186,014 (+116.3%) | $3.06M (+126.9%) | 0.2% | $20.53 | +0.7% | COM | 61225M102 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RNAM | AVIDITY BIOSCIENCES INC | 1,000,000 | $72.13M | 5.5% | $14.11 | +415.0% | — | 05370A108 |
| SPRY | ARS PHARMACEUTICALS INC | 1,600,000 | $18.64M | 1.4% | $14.35 | -28.7% | — | 82835W108 |
| UNH | UNITEDHEALTH GROUP INC | 50,000 | $16.51M | 1.2% | $318.07 | -2.9% | — | 91324P102 |
| DXCM | DEXCOM INC | 175,000 | $11.61M | 0.9% | $64.65 | +9.7% | — | 252131107 |
| CI | THE CIGNA GROUP | 40,000 | $11.01M | 0.8% | $279.23 | +0.5% | — | 125523100 |
| INCY | INCYTE CORP | 100,000 | $9.877M | 0.7% | $79.04 | +30.5% | — | 45337C102 |
| LEGN | LEGEND BIOTECH CORP | 215,000 | $4.674M | 0.4% | $21.74 | — | — | 52490G102 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ILMN | ILLUMINA INC | 530,000 (-11.7%) | $65.33M (-17.0%) | 4.9% | $116.59 | +16.2% | COM | 452327109 |
| BEAM | BEAM THERAPEUTICS INC | 1,350,000 (-15.6%) | $32.17M (-27.5%) | 2.4% | $36.48 | -20.0% | COM | 07373V105 |
| GH | GUARDANT HEALTH INC | 315,000 (-17.1%) | $29.1M (-25.0%) | 2.2% | $72.99 | +47.2% | COM | 40131M109 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 723,767 (-82.9%) | $955K (-87.9%) | 0.1% | $3.55 | -43.0% | COM | 69404D108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WGS | GENEDX HOLDINGS CORP | 3,007,164 | $193M | 14.6% | $9.11 | +1009.6% | COM CL A | 81663L200 |
| RVMD | REVOLUTION MEDICINES INC | 2,577,333 | $251M | 19.0% | $25.89 | +297.8% | COM | 76155X100 |
| LAB | STANDARD BIOTOOLS INC | 88,783,856 | $81.62M | 6.2% | $2.16 | -37.6% | COM | 34385P108 |
| BLFS | BIOLIFE SOLUTIONS INC | 5,957,165 | $114M | 8.6% | $19.43 | +21.4% | COM NEW | 09062W204 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,175,000 | $56.63M | 4.3% | $28.16 | — | SPONSORED ADS | 86366E106 |
| MAZE | MAZE THERAPEUTICS INC | 758,857 | $22.65M | 1.7% | $12.04 | +265.8% | COM | 578784100 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 75,000 | $24.82M | 1.9% | $219.27 | +61.1% | COM | 02043Q107 |
| DNLI | DENALI THERAPEUTICS INC | 1,840,000 | $35.33M | 2.7% | $22.98 | -14.6% | COM | 24823R105 |
| TEM | TEMPUS AI INC | 294,127 | $13.3M | 1.0% | $70.04 | -12.6% | CL A | 88023B103 |
| VCYT | VERACYTE INC | 276,308 | $8.9M | 0.7% | $24.40 | +61.2% | COM | 92337F107 |
| SEPN | SEPTERNA INC | 553,268 | $13.3M | 1.0% | $23.65 | +12.1% | COM | 81734D104 |
| IPSC | CENTURY THERAPEUTICS INC | 1,228,190 | $2.776M | 0.2% | $10.97 | -82.4% | COM | 15673T100 |
| DGX | QUEST DIAGNOSTICS INC | 50,000 | $9.799M | 0.7% | $182.07 | +4.7% | COM | 74834L100 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 282,312 | $2.527M | 0.2% | $11.58 | — | COM NEW | 107924102 |
| ABSI | ABSCI CORPORATION | 973,260 | $2.92M | 0.2% | $19.41 | -84.5% | COM | 00091E109 |
| CTNM | CONTINEUM THERAPEUTICS INC | 148,333 | $1.937M | 0.1% | $16.10 | -17.1% | CL A | 21217B100 |
| RXRX | RECURSION PHARMACEUTICALS IN | 165,323 | $508K | 0.0% | $6.72 | -37.9% | CL A | 75629V104 |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 36,493 | $224K | 0.0% | $10.02 | -6.9% | CL A NEW | 37611X209 |
| PRME | PRIME MEDICINE INC | 3,167,175 | $11.02M | 0.8% | $4.73 | -19.6% | COM | 74168J101 |
| TNYA | TENAYA THERAPEUTICS INC | 361,969 | $251K | 0.0% | $12.86 | -94.4% | COM | 87990A106 |